GPP
Great Point Partners’s VYNE Therapeutics VYNE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-1,652,013
| Closed | -$4.43M | – | 39 |
|
2020
Q1 | $4.43M | Hold |
1,652,013
| – | – | 0.46% | 28 |
|
2019
Q4 | $7.67M | Hold |
1,652,013
| – | – | 0.67% | 24 |
|
2019
Q3 | $7.4M | Sell |
1,652,013
-81,869
| -5% | -$367K | 0.68% | 27 |
|
2019
Q2 | $10.4M | Sell |
1,733,882
-323,145
| -16% | -$1.94M | 1.15% | 18 |
|
2019
Q1 | $16.1M | Sell |
2,057,027
-147,380
| -7% | -$1.16M | 1.6% | 20 |
|
2018
Q4 | $9.08M | Buy |
2,204,407
+900,000
| +69% | +$3.71M | 1.15% | 27 |
|
2018
Q3 | $12.8M | Buy |
+1,304,407
| New | +$12.8M | 2% | 19 |
|
2018
Q2 | – | Sell |
-52,008
| Closed | -$1.95M | – | 37 |
|
2018
Q1 | $1.95M | Buy |
+52,008
| New | +$1.95M | 0.29% | 27 |
|